ArticleDrug delivery and translational research2011

Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage.

Seema Betigeri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.